<DOC>
	<DOCNO>NCT00704496</DOCNO>
	<brief_summary>The hypothesis pseudoephedrine , sympathomimetic amine commonly use decongestant , decrease nasal congestion lead increased patency nose decrease nighttime sleep fragmentation individual year round perennial allergic rhinitis ( PAR ) . This decrease sleep fragmentation reduce daytime somnolence fatigue .</brief_summary>
	<brief_title>The Effect Pseudoephedrine Rhinitis Sleep</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>1 . Age 18 65 . 2 . History allergic rhinitis . 3 . The ability place placebo without significant compromise quality life . 4 . General good health . 5 . Ability comply protocol sign inform consent . 6 . Have daytime sleepiness history . 7 . Have poor sleep history . 8 . Have fatigue history . 9 . Have skin test RAST test perennial allergen ( indoor mold , dog , cat , mite ) correlating symptom . 1 . Age fewer 18 65 year . 2 . A history sleep apnea . 3 . Atopic diseases allergic rhinitis , atopic dermatitis asthma . 4 . Nonallergic rhinitis . 5 . Hypertension 6 . Diabetes Mellitus 7 . Inability tolerate pseudoephedrine 8 . Significant disease determine investigator . 9 . Use research medication within 30 day . 10 . Use nasal steroid topical antihistamine decongestant within 30 day . 11 . Use betablockers , antidepressant , oral decongestant , oral steroid , H2blockers . 12 . Excessive use alcohol drug abuse . 13 . Inability stop medication use runin period . 14 . Use oral antihistamine within 1 week enrollment . 15 . Failed benefit pseudoephedrine use rhinitis asthma past</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Sleep , Pseudoephedrine</keyword>
</DOC>